Fidelity Disruptive Medicine ETF (NASDAQ:FMED – Get Free Report) was the recipient of a significant increase in short interest in September. As of September 15th, there was short interest totalling 10,100 shares, an increase of 71.2% from the August 31st total of 5,900 shares. Based on an average daily trading volume, of 5,800 shares, the days-to-cover ratio is currently 1.7 days.
Institutional Trading of Fidelity Disruptive Medicine ETF
An institutional investor recently raised its position in Fidelity Disruptive Medicine ETF stock. Wealth Enhancement Advisory Services LLC grew its holdings in shares of Fidelity Disruptive Medicine ETF (NASDAQ:FMED – Free Report) by 4.8% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 520,587 shares of the company’s stock after purchasing an additional 23,730 shares during the quarter. Wealth Enhancement Advisory Services LLC owned approximately 24.56% of Fidelity Disruptive Medicine ETF worth $12,527,000 as of its most recent filing with the Securities & Exchange Commission.
Fidelity Disruptive Medicine ETF Stock Performance
Shares of FMED stock traded down $0.01 on Friday, hitting $26.10. 2,516 shares of the company’s stock traded hands, compared to its average volume of 5,681. Fidelity Disruptive Medicine ETF has a one year low of $19.88 and a one year high of $26.68. The stock has a market capitalization of $55.33 million, a price-to-earnings ratio of 35.73 and a beta of 0.94. The company’s fifty day simple moving average is $25.49 and its 200 day simple moving average is $24.72.
About Fidelity Disruptive Medicine ETF
The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.
Recommended Stories
- Five stocks we like better than Fidelity Disruptive Medicine ETF
- EV Stocks and How to Profit from Them
- CarMax’s Impressive Rally: What Investors Should Watch Next
- What is MarketRank™? How to Use it
- MarketBeat Week in Review – 9/23 – 9/27
- What Are the U.K. Market Holidays? How to Invest and Trade
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Fidelity Disruptive Medicine ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fidelity Disruptive Medicine ETF and related companies with MarketBeat.com's FREE daily email newsletter.
